semaglutide approval for mash πExciting news that is now FDA approved (aka fatty liver disease) βAt week 72, the primary efficacy endpoint was based on histology (liver biopsy results). Interim results showed 63% GLP-1 BREAKTHROUGH: FDA APPROVES TREATMENT
Pay in 4 interest-free payments of $6.30 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 14 - Aug 19



























